FDA Adverse Event Injury Summary report: N

PINN LNR CON +4 NEUT 32IDX54OD

MDR report key: 3833633 · Received May 27, 2014

Report

Report Number
1818910-2014-19492
Event Type
Injury
Date Received
May 27, 2014
Date of Event
May 1, 2014
Report Date
May 1, 2014
Manufacturer
DEPUY ORTHOPAEDICS, INC. 1818910
Product Code
KWA
PMA / PMN Number
PK043058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICES ASSOCIATED WITH THIS REPORT WERE NOT RETURNED. A REVIEW OF THE DEVICE HISTORY RECORDS FOR THE PROVIDED PRODUCT AND LOT COMBINATIONS DID NOT REVEAL ANY RELATED MANUFACTURING DEVIATIONS OR ANOMALIES. REQUESTS FOR ADDITIONAL INVESTIGATIONAL INPUTS WERE MADE IN ACCORDANCE WITH WI-7915 APPENDIX A. AN X-RAY IMAGE WAS OBTAINED AND REVIEWED BY ENGINEERING. NO OBVIOUS ABNORMALITIES ARE PRESENT THAT WOULD HAVE LED TO DISASSOCIATION OR EXCESSIVE WEAR. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITH THE INFORMATION PROVIDED. BASED ON THE INABILITY TO IDENTIFY ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Additional Manufacturer Narrative · 1

ADDITIONAL NARRATIVE:IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Description of Event or Problem · 1

THE PATIENT WAS REVISED BECAUSE OF POLY WEAR OF THE LINER AND DISASSOCIATION OF THE LINER FROM THE SHELL AND BROKEN LOCKING RING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
310453 PINN LNR CON +4 NEUT 32IDX54OD HIP ACETABULAR INSERT/LINER KWA DEPUY ORTHOPAEDICS, INC. 1818910 EH7J51000

Patients

Seq Age Sex Outcome Treatment
1 53 YR Required Intervention